Clinical trial
A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients…
NCT00039754 · Poniard Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00039754 |
|---|---|
| Title | A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma |
| Official title | A Multicenter Dosimetry Trial to Evaluate Radiation Absorbed Dose From Holmium-166-DOTMP in Patients With Multiple Myeloma |
| Lead sponsor | Poniard Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Holmium-166-DOTMP |
| Start date | Mar 1, 2002 |
| First posted | Jun 11, 2002 |
| Last update posted | Jan 21, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: